13F-HR/A filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR/A for the quarter ended 2019-12-31, filed 2020-06-17, with 33 holding rows worth $158,691,000.
- Accession
- 0000919574-20-004167
- Filer
- CIK 1791827
- Filed
- 2020-06-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, amendment of type new holdings, 33 entries on the cover page, a total value of $158,691,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $158,691,000 with VALUE read as thousands by filing date, 13F file number 028-20028. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BAXTER INTL INC | 071813109 | COM | 165,000 | $13,797,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 62,700 | $9,268,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 40,000 | $8,758,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 94,000 | $8,323,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 64,000 | $8,247,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 54,500 | $8,158,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 130,400 | $7,776,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 27,000 | $6,299,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 30,000 | $6,135,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 42,100 | $5,857,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 208,000 | $5,764,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 150,000 | $5,430,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 93,000 | $5,239,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 92,000 | $5,180,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 232,000 | $4,700,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 780,000 | $4,462,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 1,325,000 | $4,333,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 19,000 | $4,156,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 200,000 | $3,946,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 55,000 | $3,941,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 214,500 | $3,862,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 830,000 | $3,760,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 180,000 | $3,704,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 33,000 | $3,547,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 140,000 | $2,962,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 31,000 | $2,867,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 210,000 | $2,587,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 54,000 | $2,310,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 15,000 | $1,367,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 30,000 | $683,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 1,400,000 | $473,000 | thousands by filing date | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 30,000 | $410,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 10,000 | $390,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-20-001350 | base | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000919574-20-004167 | this filing | 2020-06-17 | acceptance time not in the bulk data set |